New blood filter may boost survival in septic shock patients on dialysis
NCT ID NCT07569406
First seen May 14, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This study looked back at 400 critically ill patients with septic shock and kidney failure who needed dialysis. Researchers compared those who received a special filter (Oxiris) that removes toxins and inflammation-causing substances to those who got standard filters. The goal was to see if the Oxiris filter was linked to better survival and kidney recovery. The study is complete, but because it is a retrospective review, it cannot prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Oxiris filter (a special blood filter that removes toxins and inflammation-causing substances during dialysis)
What this could lead to
If the Oxiris filter is shown to improve survival and kidney recovery, it could become a standard tool for treating septic shock in intensive care.
What could go wrong
This is a retrospective study, not a controlled trial, so results may be influenced by other factors. The filter is already available, but its benefit over standard filters remains uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.